129 related articles for article (PubMed ID: 19077745)
21. Agminated atypical (dysplastic) nevi: case report and review of the literature.
Marghoob AA; Blum R; Nossa R; Busam KJ; Sachs D; Halpern A
Arch Dermatol; 2001 Jul; 137(7):917-20. PubMed ID: 11453811
[TBL] [Abstract][Full Text] [Related]
22. Dysplastic nevi with severe atypia: Long-term outcomes in patients with and without re-excision.
Engeln K; Peters K; Ho J; Jedrych J; Winger D; Ferris LK; Patton T
J Am Acad Dermatol; 2017 Feb; 76(2):244-249. PubMed ID: 27838051
[TBL] [Abstract][Full Text] [Related]
23. Atypical melanocytic lesions of the thigh with spitzoid and dysplastic features: a clinicopathologic study of 29 cases.
Buonaccorsi JN; Lynott J; Plaza JA
Ann Diagn Pathol; 2013 Jun; 17(3):265-9. PubMed ID: 23312707
[TBL] [Abstract][Full Text] [Related]
24. Recurrence of moderately dysplastic nevi with positive histologic margins.
Hiscox B; Hardin MR; Orengo IF; Rosen T; Mir M; Diwan AH
J Am Acad Dermatol; 2017 Mar; 76(3):527-530. PubMed ID: 28027827
[TBL] [Abstract][Full Text] [Related]
25. Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.
Kolman O; Hoang MP; Piris A; Mihm MC; Duncan LM
J Am Acad Dermatol; 2010 Oct; 63(4):661-7. PubMed ID: 20846568
[TBL] [Abstract][Full Text] [Related]
26. Atypical genital nevi. A clinicopathologic analysis of 56 cases.
Gleason BC; Hirsch MS; Nucci MR; Schmidt BA; Zembowicz A; Mihm MC; McKee PH; Brenn T
Am J Surg Pathol; 2008 Jan; 32(1):51-7. PubMed ID: 18162770
[TBL] [Abstract][Full Text] [Related]
27. Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi.
Goodson AG; Florell SR; Boucher KM; Grossman D
J Am Acad Dermatol; 2010 Apr; 62(4):591-6. PubMed ID: 20018406
[TBL] [Abstract][Full Text] [Related]
28. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
29. Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border.
Hocker TL; Alikhan A; Comfere NI; Peters MS
J Am Acad Dermatol; 2013 Apr; 68(4):545-551. PubMed ID: 23127472
[TBL] [Abstract][Full Text] [Related]
30. The natural history of dysplastic nevi. A case history illustrating their evolution.
Barnes LM; Nordlund JJ
Arch Dermatol; 1987 Aug; 123(8):1059-61. PubMed ID: 3631984
[TBL] [Abstract][Full Text] [Related]
31. What Is the Best Method for Removing Biopsy-Proven Atypical Nevi? A Comparison of Margin Clearance Rates Between Reshave and Full-Thickness Surgical Excisions.
Jeon H; Wang YJ; Smart C
Dermatol Surg; 2015 Sep; 41(9):1020-3. PubMed ID: 26230329
[TBL] [Abstract][Full Text] [Related]
32. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
Ribé A
J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
[TBL] [Abstract][Full Text] [Related]
33. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
34. State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop.
Barnhill RL; Cerroni L; Cook M; Elder DE; Kerl H; LeBoit PE; McCarthy SW; Mihm MC; Mooi WJ; Piepkorn MW; Prieto VG; Scolyer RA
Adv Anat Pathol; 2010 Mar; 17(2):73-90. PubMed ID: 20179431
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic.
Lasithiotakis KG; Kokolakis A; Giannikaki E; Krasagakis K; Tosca A
Melanoma Res; 2011 Oct; 21(5):469-73. PubMed ID: 21760555
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?
Decarlo K; Yang S; Emley A; Wajapeyee N; Green M; Mahalingam M
Hum Pathol; 2010 Jun; 41(6):886-94. PubMed ID: 20233623
[TBL] [Abstract][Full Text] [Related]
37. In vivo confocal microscopy for detection and grading of dysplastic nevi: a pilot study.
Pellacani G; Farnetani F; Gonzalez S; Longo C; Cesinaro AM; Casari A; Beretti F; Seidenari S; Gill M
J Am Acad Dermatol; 2012 Mar; 66(3):e109-21. PubMed ID: 21742408
[TBL] [Abstract][Full Text] [Related]
38. Dysplastic vulvar nevi.
Blickstein I; Feldberg E; Dgani R; Ben-Hur H; Czernobilsky B
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):968-70. PubMed ID: 1923241
[TBL] [Abstract][Full Text] [Related]
39. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
40. [Thermographic examination of cutaneous melanocytic nevi].
Mikulska D
Ann Acad Med Stetin; 2009; 55(1):31-8; discussion 38. PubMed ID: 20349589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
